Skip to main content
. 2009 Oct 21;12(1):103–110. doi: 10.1007/s12028-009-9292-y

Table 3.

Routine studies for the potential organ donor

Team requesting/performing studies Clinical studies Timing
Organ donor network Serum: HIV 1,2 antibody; HTLV 1,2 antibody; Hepatitis B surface antigen, Hepatitis B core antibody, Hepatitis B core IgM, Hepatitis C antibody, Hepatitis B/C and HIV RNA testing, CMV IgM and IgG, EBV IgM and IgG, RPR, toxoplasmosis IgG, Chagas disease antibody (for patients with travel to Texas or South America) Once
Primary care team Serum: Complete blood count, arterial blood gas, liver function tests including GGT, coagulation studies, fibrinogen, troponin/CK, chemistry panel including calcium, phospohorus and magnesium, LDH, amylase, lipase Every 6 h
Primary care team CXR, ECG, blood culture, urine culture, urinalysis, sputum culture and gram stain, HgbA1c (once), type and screen (once) Daily and as needed
Primary care team 2-D Transthoracic echocardiogram At least once, may repeat depending on hemodynamic status
Organ donor network/primary care team/cardiology Coronary catheterization May be required for potential heart donors
Organ donor network/primary care team/pulmonology Bronchoscopy Required for potential lung donors

HTLV Human T lymphotrophic virus, EBV Epstein-Barr virus, CMV cytomegalovirus, CXR chest X-ray, ECG electrocardiogram